Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01948271 · ClinicalTrials.gov registry record · Phase 1
Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis
A Phase 1 study, sponsored by Tufts Medical Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT01948271: Clinical Trial Phase 1 study, sponsored by Tufts Medical Center.
NCT01948271 is a Phase 1 study that was terminated before completion, run by Tufts Medical Center. The registered enrollment target is 3 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01948271, a Phase 1 study, was terminated before completion, sponsored by Tufts Medical Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this research study is to better understand whether trichuris suis ova (TSO) ingested orally may be safe and effective in the treatment of psoriasis.
Primary Outcome
The PASI is a system used for assessing and grading the severity of psoriatic lesions and their response to therapy. PASI produces a numeric score that can range from 0 to 72 based on the body surface area of involvement and the severity of disease (induration, erythema and scale). A PASI-50 response is defined as ≥50% improvement in PASI score from baseline; PASI-75 and PASI-90 are similarly defined.
Interventions
- DRUG Trichuris Suis Ova
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-09 |
| Phase | Phase 1 |
Why NCT01948271 stopped before completion
NCT01948271 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Trichuris Suis Ova is the first listed.
NCT01948271 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01948271 about?
NCT01948271 is a clinical study titled "Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis". The purpose of this research study is to better understand whether trichuris suis ova (TSO) ingested orally may be safe and effective in the treatment of psoriasis.
What is the current status of trial NCT01948271?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2013-07. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01948271?
The interventions under investigation include: Trichuris Suis Ova (DRUG).
Who is sponsoring clinical trial NCT01948271?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01948271's enrollment target sits among peer trials
3 1999th of 2000 higher than 1 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia